Back

Anaconda Biomed closes $56 million financing for stroke catheter development

Verifying
  • Anaconda Biomed closed a $56 million financing round for stroke-device development.
  • $56 million will fund product development, clinical work and the ATHENA pivotal IDE study.
  • ATHENA is a prospective, randomized trial designed to evaluate the ANA Funnel Catheter in 327 subjects.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.